{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:53:58Z","timestamp":1760316838658,"version":"build-2065373602"},"reference-count":89,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.schres.2011.10.013","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T23:25:36Z","timestamp":1321917936000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion"],"prefix":"10.1016","volume":"136","author":[{"given":"Ricardo","family":"C\u00e1ceda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Kinkead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.10.013_bb0265","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1460-9568.1999.00506.x","article-title":"Blockade of neurotensin receptors suppresses the dopamine D1\/D2 synergism on immediate early gene expression in the rat brain","volume":"11","author":"Alonso","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-8993(96)00140-0","article-title":"Amphetamine induces Fos-like immunoreactivity in the striatum of primates","volume":"719","author":"Asin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-003-1436-8","article-title":"Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats","volume":"168","author":"Bauco","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(90)90721-K","article-title":"Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex","volume":"108","author":"Bean","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2011.10.013_bb0285","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.npp.1395212","article-title":"Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine","volume":"19","author":"Betancur","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0290","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1523\/JNEUROSCI.22-14-05817.2002","article-title":"Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral sensitization to cocaine","volume":"22","author":"Beurrier","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1523\/JNEUROSCI.21-02-00601.2001","article-title":"Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating","volume":"21","author":"Binder","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0300","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0031-6997(24)01509-6","article-title":"Neurotensin and dopamine interactions","volume":"53","author":"Binder","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.schres.2011.10.013_bb0305","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/sj.npp.1300546","article-title":"Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs","volume":"29","author":"Binder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(01)01197-9","article-title":"A novel neurotensin analog blocks cocaine- and d-amphetamine-induced hyperactivity","volume":"426","author":"Boules","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200721010-00002","article-title":"Neurotensin agonists: potential in the treatment of schizophrenia","volume":"21","author":"Boules","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2011.10.013_bb0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2009.10.050","article-title":"NT79: a novel neurotensin analog with selective behavioral effects","volume":"1308","author":"Boules","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1026309727518","article-title":"At least three neurotransmitter systems mediate a stress-induced increase in c-fos mRNA in different rat brain areas","volume":"17","author":"Bozas","year":"1997","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.schres.2011.10.013_bb0330","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.4178-03.2004","article-title":"Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo","volume":"24","author":"Brady","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0335","first-page":"1","article-title":"Virally mediated increase in neurotensin 1 receptor in the nucleus accumbens decreases the behavioral effects of mesolimbic system activation by amphetamine and dizocilpine","volume":"110","author":"C\u00e1ceda","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0340","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.peptides.2006.04.024","article-title":"Neurotensin role in psychiatric and neurological diseases","volume":"27","author":"C\u00e1ceda","year":"2006","journal-title":"Peptides"},{"issue":"Suppl 1","key":"10.1016\/j.schres.2011.10.013_bb0345","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1055\/s-2006-931483","article-title":"The neurochemical circuitry of schizophrenia","volume":"39","author":"Carlsson","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2011.10.013_bb0350","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/S0021-9258(19)43429-7","article-title":"The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami","volume":"248","author":"Carraway","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2011.10.013_bb0355","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuropharm.2004.03.001","article-title":"Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice","volume":"47","author":"Casti","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0360","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1471-4159.1992.tb11358.x","article-title":"D1 dopamine receptor activation of multiple transcription factor genes in rat striatum","volume":"58","author":"Cole","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2011.10.013_bb0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(01)01271-7","article-title":"The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice","volume":"428","author":"Costa","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.npep.2006.12.001","article-title":"Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability","volume":"41","author":"Costa","year":"2007","journal-title":"Neuropeptides"},{"key":"10.1016\/j.schres.2011.10.013_bb0375","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(95)00794-Q","article-title":"Amphetamine induction of c-fos in the nucleus accumbens is not inhibited by glutamate antagonists","volume":"694","author":"Dalia","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0380","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.890130308","article-title":"Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields","volume":"13","author":"Dilts","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.schres.2011.10.013_bb0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(90)90341-6","article-title":"MK-801 induces c-fos protein in thalamic and neocortical neurons of rat brain","volume":"111","author":"Dragunow","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2011.10.013_bb0390","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(92)90698-7","article-title":"Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex","volume":"140","author":"During","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2011.10.013_bb0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/291073a0","article-title":"Neurotensin blocks certain amphetamine-induced behaviours","volume":"291","author":"Ervin","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.schres.2011.10.013_bb0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(01)01708-6","article-title":"The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat","volume":"303","author":"Fadel","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2011.10.013_bb0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2006.03.043","article-title":"Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice","volume":"402","author":"Fadel","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2011.10.013_bb0410","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0006-8993(00)02654-8","article-title":"Effects of prefrontal cortex microinjection of neurotensin-(8\u201313) on midbrain dopamine and non-dopamine cell firing","volume":"876","author":"Fatigati","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0415","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130050811","article-title":"Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating","volume":"141","author":"Feifel","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(99)00123-0","article-title":"Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle","volume":"106","author":"Feifel","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(97)00306-5","article-title":"The effects of intra-accumbens neurotensin on sensorimotor gating","volume":"760","author":"Feifel","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0430","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-3565(24)38010-3","article-title":"Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist","volume":"288","author":"Feifel","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2011.10.013_bb0435","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0893-133X(00)00235-9","article-title":"Startle and sensorimotor gating in rats lacking CCK-A receptors","volume":"24","author":"Feifel","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuropharm.2009.07.002","article-title":"Sensorimotor gating in neurotensin-1 receptor null mice","volume":"58","author":"Feifel","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00235-1","article-title":"Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine","volume":"398","author":"Fujimura","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<14::AID-SYN2>3.0.CO;2-E","article-title":"Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain","volume":"29","author":"Gao","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.schres.2011.10.013_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00304474","article-title":"Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-d-aspartate receptor antagonist MK-801","volume":"84","author":"Gass","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.schres.2011.10.013_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0306-4522(93)90621-L","article-title":"Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-d-aspartate receptor antagonist MK-801","volume":"53","author":"Gass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1460-9568.2006.04928.x","article-title":"Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of their origins and [2] responses to acute psychostimulant and antipsychotic drug administration","volume":"24","author":"Geisler","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0269881106081528","article-title":"Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect","volume":"22","author":"Grimond-Billa","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1472-8206.1995.tb00528.x","article-title":"Neuropharmacological profile of non-peptide neurotensin antagonists","volume":"9","author":"Gully","year":"1995","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-3565(24)36482-1","article-title":"Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist","volume":"280","author":"Gully","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2011.10.013_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(95)00127-7","article-title":"Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment","volume":"278","author":"Hanson","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0045","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1523\/JNEUROSCI.17-14-05271.1997","article-title":"A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release","volume":"17","author":"Harvey","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(01)01076-7","article-title":"Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity","volume":"422","author":"Hertel","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0055","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1523\/JNEUROSCI.3280-04.2004","article-title":"Dopamine excites nucleus accumbens neurons through the differential modulation of glutamate and GABA release","volume":"24","author":"Hjelmstad","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0306-4522(94)00537-F","article-title":"Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons","volume":"65","author":"Jaber","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0014-2999(82)90491-5","article-title":"Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin","volume":"78","author":"Kalivas","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0306-4522(83)90195-1","article-title":"Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat","volume":"8","author":"Kalivas","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0306-4522(84)90203-3","article-title":"Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing","volume":"11","author":"Kalivas","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0080","doi-asserted-by":"crossref","unstructured":"Kinkead, B., Dobner, P.R., Egnatashvili, V., Murray, T., Deitemeyer, N., Nemeroff, C.B., 2005. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine or quetiapine. J. Pharmacol. Exp. Ther. 315, 256\u2013264.","DOI":"10.1124\/jpet.105.087437"},{"key":"10.1016\/j.schres.2011.10.013_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","article-title":"The neurobiology of startle","volume":"59","author":"Koch","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2011.10.013_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5347(25)00293-9","article-title":"Effect of methamphetamine on neurotensin concentrations in rat brain regions","volume":"241","author":"Letter","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2011.10.013_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2009.11.048","article-title":"The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex","volume":"1311","author":"Li","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuropharm.2008.03.001","article-title":"Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice","volume":"54","author":"Marie-Claire","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/mcne.1994.1040","article-title":"c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin\/neuromedin N mRNA expression in rat dorsal striatum","volume":"5","author":"Merchant","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.schres.2011.10.013_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(88)90581-X","article-title":"Changes in the limbic neurotensin systems induced by dopaminergic drugs","volume":"153","author":"Merchant","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0022-3565(25)38766-5","article-title":"Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects","volume":"269","author":"Merchant","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2011.10.013_bb0120","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/sj.npp.1300548","article-title":"Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction","volume":"29","author":"Miyamoto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0125","series-title":"Limbic Motor Circuits and Neuropsychiatry","first-page":"193","article-title":"From motivation to action: a review of dopaminergic regulation of limbic-nucleus accumbens-ventral pallidum-pedunculopontine nucleus circuitries involved in limbic-motor integration","author":"Mogenson","year":"1993"},{"key":"10.1016\/j.schres.2011.10.013_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-4547(19960701)45:1<13::AID-JNR2>3.0.CO;2-K","article-title":"Effects of phencyclidine on immediate early gene expression in the brain","volume":"45","author":"Nakki","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0269881107083838","article-title":"Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion","volume":"22","author":"Norman","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269881108097721","article-title":"A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning","volume":"24","author":"Norman","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0196-9781(90)90058-D","article-title":"Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner","volume":"11","author":"Nouel","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.schres.2011.10.013_bb0150","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.npp.1300638","article-title":"Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization","volume":"30","author":"Panayi","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(97)83023-3","article-title":"Activation of c-fos mRNA in the brain by the kappa-opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine","volume":"328","author":"Panegyres","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-4522(94)00582-P","article-title":"Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity","volume":"66","author":"Paul","year":"1995","journal-title":"Neuroscience"},{"year":"1986","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.schres.2011.10.013_bb0165"},{"key":"10.1016\/j.schres.2011.10.013_bb0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0301-0082(94)90025-6","article-title":"The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data","volume":"42","author":"Pennartz","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2011.10.013_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02245067","article-title":"Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats","volume":"116","author":"Poncelet","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(93)90808-Z","article-title":"Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat","volume":"622","author":"Robledo","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(02)01622-9","article-title":"Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition","volume":"444","author":"Schwienbacher","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.1992.tb27345.x","article-title":"Actions of neurotensin: a review of the electrophysiological studies","volume":"668","author":"Shi","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2011.10.013_bb0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0166-4328(03)00037-8","article-title":"The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition","volume":"143","author":"Shilling","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0361-9230(99)00036-2","article-title":"Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window","volume":"48","author":"Sills","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.schres.2011.10.013_bb0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1179\/014788889794651870","article-title":"A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes","volume":"12","author":"Simmons","year":"1989","journal-title":"J. Histotechnol."},{"key":"10.1016\/j.schres.2011.10.013_bb0210","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0306-4522(94)90295-X","article-title":"SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission","volume":"59","author":"Steinberg","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0278-5846(91)90072-9","article-title":"Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat","volume":"15","author":"Swerdlow","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2011.10.013_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2011.10.013_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0361-9230(02)00965-6","article-title":"Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex","volume":"59","author":"Szakacs","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.schres.2011.10.013_bb0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03040-2","article-title":"Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens","volume":"920","author":"Uslaner","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2011.10.013_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(98)00678-5","article-title":"Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells","volume":"360","author":"Vita","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2011.10.013_bb0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(94)91343-9","article-title":"Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity","volume":"665","author":"Wagstaff","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-8993(96)01380-7","article-title":"Role of dopamine D1- and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens","volume":"748","author":"Wagstaff","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2011.10.013_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-4522(95)00100-W","article-title":"A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif\/268 and preprodynorphin messenger RNA expression in rat forebrain","volume":"68","author":"Wang","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2011.10.013_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(00)01269-6","article-title":"A comparison of the patterns of striatal Fos-like immunoreactivity induced by various dopamine agonists in rats","volume":"289","author":"Wirtshafter","year":"2000","journal-title":"Neurosci. Lett."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411005482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:25:25Z","timestamp":1760297125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411005482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":89,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0920996411005482"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.013","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2011.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}